Showing 381 - 400 results of 778 for search '"Prostate cancer"', query time: 0.08s Refine Results
  1. 381
  2. 382

    Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain by Eva Tirado Mercier, Daniel Callejo Velasco, Marta Rubio Cabezas, Cristina Moretones Agut, Meritxell Granell Villalón

    Published 2018-01-01
    “…**Purpose:** To perform a cost-effectiveness analysis of radium-223 plus Best Supportive Care (BSC) compared to BSC in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and without previous docetaxel treatment in Spain. …”
    Get full text
    Article
  3. 383
  4. 384

    Stomach Metastasis in a Patient with Prostate Cancer 4 Years after the Initial Diagnosis: A Case Report and a Literature Review by Ahmet Bilici, Mustafa Dikilitas, Ozlem Ton Eryilmaz, Bekir Selim Bagli, Fatih Selcukbiricik

    Published 2012-01-01
    “…Prostate cancer commonly metastasizes bones and lymph nodes, but it very rarely spreads to the gastrointestinal tract. …”
    Get full text
    Article
  5. 385
  6. 386

    A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer by Noriyuki Okonogi, MD, PhD, Hiroshi Tsuji, MD, PhD, Kana Kobayashi, MD, PhD, Mio Nakajima, MD, PhD, Shuri Aoki, MD, PhD, Takanobu Utsumi, MD, PhD, Hiroyoshi Suzuki, MD, PhD, Koichiro Akakura, MD, PhD, Tomohiko Ichikawa, MD, PhD, Hitoshi Ishikawa, MD, PhD

    Published 2025-03-01
    “…Purpose: We report herein the 3-year results of a phase I/II prospective study of 4-fraction course of carbon-ion radiation therapy (CIRT) in patients with localized prostate cancer. Methods and Materials: The present was a single-institution, phase I/II prospective study including patients with low- or intermediate-risk prostate cancer, as defined by the National Comprehensive Cancer Network criteria. …”
    Get full text
    Article
  7. 387

    Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa by Ajay Aggarwal, Janet Seeley, Virginia Bond, Kennedy Lishimpi, John Kachimba, Musonda Simwinga, Andrew Sentoogo Ssemata, Susan Msadabwe, Dorothy Chilambe Lombe, Monde Mwamba, Richard Muhumuza, Victor Mapulanga

    Published 2024-07-01
    “…National priority research areas for prostate cancer in Zambia were identified as prostate cancer awareness; building affordable high-quality diagnostic capacity; affordability of specialist cancer treatments; supporting better access to medicines; delivery and coordination of services across the pathway and staff training.Conclusion The suggested seven priority areas allow for the development of the prostate cancer control programme to be conducted in a holistic manner. …”
    Get full text
    Article
  8. 388
  9. 389
  10. 390
  11. 391

    Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases by Dae Yul Yang, Won-Woo Seo, Rae Woong Park, Sang Youl Rhee, Jae Myung Cha, Yoon Soo Hah, Chang Won Jeong, Kyung-Jin Kim, Hyeon-Jong Yang, Do Kyung Kim, Ji Yong Ha

    Published 2025-01-01
    “…Previous studies suggest the possibility that dutasteride may be superior to finasteride in preventing prostate cancer. We directly compared the effects of finasteride and dutasteride on the risk of prostate cancer in patients with BPH using a pooled analysis of 15 real-world databases. …”
    Article
  12. 392
  13. 393

    Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation by Bradley A. Wall, Daniel A. Galvão, Naeem Fatehee, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton

    Published 2015-01-01
    “…One hundred and seven men (42–89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for resting metabolic rate, body composition, blood pressure and arterial stiffness, and blood biomarker analysis. …”
    Get full text
    Article
  14. 394
  15. 395

    Unsupervised self-organising map classification of Raman spectra from prostate cell lines uncovers substratified prostate cancer disease states by Daniel West, Susan Stepney, Y. Hancock

    Published 2025-01-01
    “…Abstract Prostate cancer is a disease which poses an interesting clinical question: Should it be treated? …”
    Get full text
    Article
  16. 396
  17. 397
  18. 398
  19. 399
  20. 400

    Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil by Fernando C. Maluf, Cintia S.K.S. de Oliveira, Patrícia K. Ziegelmann

    Published 2025-02-01
    “…PURPOSEWe investigated the impact of the funding source (public v private) on the overall survival (OS) of men with prostate cancer in Brazil.METHODSWe retrospectively analyzed patients with prostate cancer from a large hospital registry from the state of São Paulo, Brazil. …”
    Get full text
    Article